Korea Investment Corp
TXG icon

Korea Investment Corp’s 10x Genomics TXG Stock Holding History

Korea Investment Corp’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,276
Closed -$239K – 771
2022
Q2 		$239K Sell
5,276
-3,224
-38% -$167K ﹤0.01% 750
2022
Q1 		$647K Sell
8,500
-7,500
-47% -$656K ﹤0.01% 718
2021
Q4 		$2.38M Buy
16,000
+3,400
+27% +$521K 0.01% 638
2021
Q3 		$1.83M Sell
12,600
-3,300
-21% -$567K 0.01% 673
2021
Q2 		$3.11M Buy
15,900
+1,100
+7% +$199K 0.01% 628
2021
Q1 		$2.68M Sell
14,800
-5,600
-27% -$967K 0.01% 621
2020
Q4 		$2.89M Buy
+20,400
New +$2.96M 0.01% 608

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Korea Investment Corp's TXG Position: Q3 2022 in Review

Korea Investment Corp sold out of 10x Genomics (TXG) in Q3 2022, closing a stake of 5,276 shares — an estimated $239K sold.

Korea Investment Corp first reported a position in TXG in Q4 2020 and held it in 7 quarters. The position peaked at $3.11M in Q2 2021. 233 funds tracked by Wall St. Rank hold TXG as of Q3 2022.

  • Korea Investment Corp reported no remaining 10x Genomics position as of Q3 2022 after selling out during the quarter.
  • Korea Investment Corp sold 5,276 10x Genomics shares in Q3 2022, an estimated $239K.
  • Korea Investment Corp first reported a position in 10x Genomics in Q4 2020 and held it in 7 quarters.
  • Korea Investment Corp's 10x Genomics position peaked at $3.11M in Q2 2021.
  • 233 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2022.

Based on Korea Investment Corp's 13F filing for Q3 2022, filed 10 Nov 2022.